Injectable antispasmodic medications for cerebral palsy

References

Citations

  1. Koman LA, et al. (2001). Botulinum toxin type A neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: A multicenter, open-label clinical trial. Pediatrics, 108(5): 1062–1071.

  2. Ade-Hall RA, Moore AP (2006). Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy. Cochrane Database of Systematic Reviews (1). Oxford: Update Software.

  3. Koman LA, et al. (2004). Cerebral palsy. Lancet, 363(9421): 1619–1631.


Author: Sabra L. Katz-Wise
Ralph Poore		Last Updated: November 20, 2006
Medical Review: Michael J. Sexton, MD - Pediatrics
Louis Pellegrino, MD - Developmental Pediatrics

© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

Click here to learn about Healthwise

Topic Contents
 Examples
 How It Works
 Why It Is Used
 How Well It Works
 Side Effects
 What To Think About
 References